M J Shah Group carries a rich legacy of over 50 years that is built on the trust and belief of its customers and stakeholders. The group began its operations in the pharmaceutical industry back in 1959 with Biochem Pharmaceutical Industries.
Biochem was a pioneer in the pharmaceutical industry with exports to eight countries, including Thailand, Malaysia, Kenya and Sri Lanka; and has a lot of firsts to its credit:
It was the first company to bring the antibiotic Ampicillin to India. In fact it was also instrumental in treating the Indian Army during the 1965 war.
Biochem also has to its credit, introducing of the first anti-cancer Mitomycin-C injections to the country under an exclusive license, from Japan. This revolutionised the way cancer patients were treated in India.
In addition, Amikacin Sulphate injections (to treat bacterial infection), were also introduced by Biochem in 1985.
In order to strategically venture into investments, the group divested the pharmaceuticals business, to begin long-term investments in leading real estate funds viz. HDFC, ICICI, Ask, Peninsula, Reliance, IIFL & Indiareit, through MJ Shah Capital.
| Plan | Area | Price | Floor Plan |
|---|---|---|---|
| 1 BHK | 389 sqft | On request | Get Floor Plan |
| 1 BHK | 389 Sqft | On request | Get Floor Plan |
| 2 BHK | 627 sqft | On request | Get Floor Plan |
| 2 BHK | 627 Sqft | On request | Get Floor Plan |
| 1.5 BHK | 486 sqft | On request | Get Floor Plan |
| 1.5 BHK | 486 Sqft | On request | Get Floor Plan |